Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer

2008; Springer Science+Business Media; Volume: 62; Issue: 1 Linguagem: Inglês

10.1007/s00280-007-0665-7

ISSN

1432-0843

Autores

J Horti, Erzsébet Juhász, Zsuzsanna Monostori, K. Maeda, S. Eckhardt, I. Bodrogi,

Tópico(s)

Cancer therapeutics and mechanisms

Referência(s)